genedrive plc (AIM:GDR)
1.097
+0.037 (3.49%)
Mar 6, 2026, 11:42 AM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 10.91 million as of March 6, 2026. Its market cap has increased by 0.47% in one year.
Market Cap
10.91M
Enterprise Value
9.73M
Revenue
954.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since April 10, 2007, genedrive's market cap has decreased from 11.67M to 10.91M, a decrease of -6.48%. That is a compound annual growth rate of -0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 10.91M | 21.14% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.14B |
| GSK plc | 83.21B |
| Haleon | 33.96B |
| Smith & Nephew | 11.10B |
| Renalytix | 14.64M |
| CelLBxHealth | 11.08M |
| Oxford BioDynamics | 10.73M |
| Genflow Biosciences | 9.25M |